List of insiders holdings for IMMUNOGEN INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | SAYARE MITCHEL Director |
2011-08-01 15:17:17 | 383,136 0 |
383,136 | Form 4 |
2 | JUNIUS DANIEL M Director |
2018-03-16 17:12:46 | 298,505 0 |
298,505 | Form 4 |
3 | Johnston David Brannon Chief Financial Officer |
2018-06-08 16:08:25 | 270,690 0 |
270,690 | Form 4 |
4 | Gregory Richard J. Executive VP & CSO |
2019-02-25 10:10:17 | 199,413 0 |
199,413 | Form 4 |
5 | ALTSCHULLER Susan SVP AND CFO |
2022-12-27 17:14:38 | 165,000 0 |
165,000 | Form 4 |
6 | BARROWS CRAIG Executive VP, General Counsel |
2020-02-25 08:36:43 | 145,275 0 |
145,275 | Form 4 |
7 | BLATTLER WALTER Executive Vice President |
2007-06-06 16:46:29 | 124,900 0 |
124,900 | Form 4 |
8 | LAMBERT JOHN Executive Vice President |
2016-11-03 11:13:47 | 120,521 0 |
120,521 | Form 4 |
9 | Berkenblit Anna SVP & CHIEF MEDICAL OFFICER |
2023-07-05 17:56:29 | 113,935 0 |
113,935 | Form 4 |
10 | Morris Charles Q Executive VP & CDO |
2016-07-20 16:10:50 | 110,000 0 |
110,000 | Form 4 |
11 | CADDEN SUZANNE VP, Regulatory & Quality |
2009-12-21 14:57:15 | 100,000 0 |
100,000 | Form 3 |
12 | MISSLING CHRISTOPHER U Chief Financial Officer |
2004-10-26 16:31:55 | 100,000 0 |
100,000 | Form 4 |
13 | VILLAFRANCA JOSEPH J Director |
2018-01-03 13:20:41 | 90,997 0 |
90,997 | Form 4 |
14 | Ryll Thomas SVP, Technical Operations |
2021-07-02 16:18:56 | 84,714 0 |
84,714 | Form 4 |
15 | O'Leary James J Vice President |
2014-07-18 10:46:09 | 80,000 0 |
80,000 | Form 4 |
16 | PIEN HOWARD H Director |
2018-01-03 13:20:24 | 78,298 0 |
78,298 | Form 4 |
17 | Harrington-Smith Kristen SVP & CHIEF COMMERCIAL OFFICER |
2022-11-18 17:31:28 | 75,000 0 |
75,000 | Form 4 |
18 | Harrison Ellie VP & Chief HR Officer |
2016-07-20 16:08:48 | 70,000 0 |
70,000 | Form 4 |
19 | SHIRE BIOCHEM INC SHIRE PHARMACEUTICALS GROUP PLC 10% Owner |
2004-06-02 19:28:29 | 66,098 0 |
66,098 | Form 13G |
20 | ONETTO NICOLE Director |
2015-11-12 08:41:50 | 63,248 0 |
63,248 | Form 4 |
21 | RYAN PAULINE JEN SVP Corporate Devlp & Ops |
2007-06-14 11:53:57 | 60,000 0 |
60,000 | Form 4 |
22 | PERRY GREGORY D Chief Financial Officer |
2013-09-11 11:10:09 | 56,665 0 |
56,665 | Form 4 |
23 | Williams Peter J. VP, Business Development |
2017-02-24 14:55:29 | 50,620 0 |
50,620 | Form 4 |
24 | FOSTER DAVID G V.P.-Fin., Prin. Acctg. Off. |
2021-01-05 08:59:20 | 38,274 0 |
38,274 | Form 4 |
25 | BELOFF GREGG Vice President and CFO |
2003-06-16 14:18:19 | 35,000 0 |
35,000 | Form 4 |
26 | LAVERY VIRGINIA VP and Senior Controller |
2004-06-21 17:01:03 | 30,000 0 |
30,000 | Form 4 |
27 | Poole Sandra Executive VP, Tech Operations |
2016-10-20 11:37:32 | 27,500 0 |
27,500 | Form 4 |
28 | Oberton Karleen Marie Senior Corporate Controller |
2005-06-13 15:15:24 | 20,000 0 |
20,000 | Form 4 |
29 | CARTER DAVID WARREN Director |
2010-11-18 09:05:02 | 10,047 0 |
10,047 | Form 4 |
30 | Tagliamonte John VP, Business Development |
2008-06-17 11:09:36 | 9,000 0 |
9,000 | Form 4/A |
31 | SKALETSKY MARK B Director |
2012-11-15 15:03:32 | 7,271 0 |
7,271 | Form 4 |
32 | FEINER STUART Director |
2006-07-05 16:41:29 | 6,231 0 |
6,231 | Form 4 |
33 | McKee Blaine H. EVP & Chief Business Officer |
2019-07-02 13:38:59 | 5,230 0 |
5,230 | Form 4 |
34 | Peterson Kristine Director |
2024-02-12 16:48:14 | 0 0 |
0 | Form 4 |
35 | MITCHELL DEAN J Director |
2024-02-12 16:48:55 | 0 0 |
0 | Form 4 |
36 | Thackray Helen M. Director |
2024-02-12 16:47:26 | 0 0 |
0 | Form 4 |
37 | Enyedy Mark J CHIEF EXECUTIVE OFFICER |
2024-02-12 16:46:37 | 0 0 |
0 | Form 4 |
38 | Wallace Richard John Director |
2024-02-12 16:45:36 | 0 0 |
0 | Form 4 |
39 | Coen Stacy Ann SVP & CHIEF BUSINESS OFFICER |
2024-02-12 16:44:41 | 0 0 |
0 | Form 4 |
40 | Lentini Renee VP & PRIN ACCTG OFFICER |
2024-02-12 16:43:42 | 0 0 |
0 | Form 4 |
41 | Goldberg Mark Alan Director |
2024-02-12 16:42:43 | 0 0 |
0 | Form 4 |
42 | Arbuckle Stuart A Director |
2024-02-12 16:41:43 | 0 0 |
0 | Form 4 |
43 | Wingrove Theresa SVP OF REGULATORY AFFAIRS |
2024-02-12 16:41:07 | 0 0 |
0 | Form 4 |
44 | MCCLUSKI STEPHEN C Director |
2024-02-12 16:40:17 | 0 0 |
0 | Form 4 |
45 | McCain Tracey L Director |
2024-02-12 16:39:18 | 0 0 |
0 | Form 4 |
46 | Kalofonos Isabel SVP & CHIEF COMMERCIAL OFFICER |
2024-02-12 16:38:17 | 0 0 |
0 | Form 4 |
47 | White Lauren SVP, CFO AND PFO |
2024-02-12 16:37:39 | 0 0 |
0 | Form 4 |
48 | Char Daniel SVP & CHIEF LEGAL OFFICER |
2024-02-12 16:36:57 | 0 0 |
0 | Form 4 |
49 | VASCONCELLES MICHAEL EVP R&D & MEDICAL AFFAIRS |
2024-02-12 16:35:42 | 0 0 |
0 | Form 4 |
50 | ZIFF ASSET MANAGEMENT LP PBK HOLDINGS INC KORSANT PHILIP B ZBI Equities L.L.C. 10% Owner |
2011-02-14 18:40:20 | 0 0 |
0 | Form 13G |
51 | SAMANA CAPITAL L.P. MORTON HOLDINGS INC. KORSANT PHILIP B 10% Owner |
2011-02-14 18:40:20 | 0 0 |
0 | Form 13G |